At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
lymphocyte depletionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
T-Cell Depletion in Unrelated Donor Marrow Transplantation
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 15, 2016
In Brief
A Phase 3 clinical trial evaluating lymphocyte depletion for Bone Marrow Transplantation and 4 related conditions. Completed.
Detailed Summary
To determine if a reduction in morbidity and mortality from acute and chronic graft versus host disease (GvHD) can be achieved through use of T-cell depletion techniques without a counterbalancing increase in relapse of leukemia in patients receiving an unrelated donor marrow transplant.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBone Marrow Transplantation, Graft vs Host Disease, Immunologic Diseases, Leukemia, Myelodysplastic Syndromes
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 1993
First PostedOct 1999
Study CompletionFeb 2005
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartNov 1, 1993
Study CompletionFeb 1, 2005
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
lymphocyte depletionprocedure